Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 5951 - 5975 of 6662 in total

N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1~7,11~]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE

Experimental

2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid

Experimental

(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide

Experimental

Selenazole-4-carboxyamide-adenine dinucleotide

Experimental

N-(2-Aminoethyl)-5-Chloroisoquinoline-8-Sulfonamide

Experimental

1-[(2-AMINO-4-CHLORO-5-METHYLPHENYL)SULFONYL]-L-PROLINE

Experimental

(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol

Experimental

B7-H3-specific chimeric antigen receptor T cells

Investigational

Golidocitinib

Investigational

3-(cyclohexylamino)propanesulfonic acid

Experimental

N-acetylserotonin

Experimental

Andarine

Andarine is a non-steroidal selective androgen receptor modulator.
Experimental

Mardepodect

Investigational

BI-836858

Investigational

RGX-111

RGX-111 is an adeno-associated virus vector AAV9 designed to deliver the α-L-iduronidase (IDUA) gene. Developed by REGENXBIO Inc., it was investigated for the treatment of mucopolysaccharidosis Type I (MPS I).
Investigational

APL-030

APL-030 is a orally-active small molecule inhibitor of GCN2.
Investigational

Panax quinquefolius whole

Panax quinquefolius whole is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Experimental
Investigational

Capsicum annuum whole

Capsicum annuum whole is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.
Experimental

Olea europaea leaf

Experimental

BBIBP-CorV

BBIBP-CorV vaccine contains a SARS-CoV-2 strain inactivated inside Vero Cells. Investigation shows this vaccine induces neutralizing antibodies in several mammalian species while also showing protective efficacy with SARS-CoV-2 challenge in rhesus macaques . As of August 2020, this vaccine is being tested for prophylaxis against COVID-19 in human clinical trials.
Investigational

C-CAR039

C-CAR039 is an autologous Chimeric Antigen Receptors (CAR) T-cell therapy expressing CD19/CD20 bi-specific CAR.
Investigational

Copper(II) dithiosemicarbazone

Experimental
Investigational

PF-4136309

Investigational

Mezigdomide

Mezigdomide is under investigation in clinical trial NCT05372354 (A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma).
Investigational

Monepantel

Investigational
Displaying drugs 5951 - 5975 of 6662 in total